Cancer Genetics and Prevention Update

by Christine Hensel Triantos

Beyond BRCA1 and BRCA2:

Other Gene Mutations Linked to Cancer Risk

Many women with a family history of breast or ovarian cancer choose genetic testing to find out if they have inherited BRCA1 or BRCA2 gene mutations, which could put them and their family members at a higher risk for these cancers. Now a panel test – known as BROCA – is available for women to learn if they have other gene mutations linked to breast and ovarian cancer.

The panel includes mutations in about 25 genes associated with an increased risk for breast or ovarian cancer, and that number is steadily growing. Many of them, including PALB2 and BARD1, were identified in Dana-Farber laboratories.

But Judy Garber, MD, MPH, a breast oncologist and director of the Center for Cancer Genetics and Prevention in the Susan F. Smith Center for Women’s Cancers at Dana-Farber, advises women and their physicians to consider this broader genetic testing very carefully. While the information helps assess increased risks of cancer, researchers are still trying to understand exactly how to manage those risks. Unlike BRCA1 and BRCA2 gene mutations have not yet been the focus of long-term, large-scale studies that help clarify effective risk reduction strategies.

“With BRCA1 and BRCA2 gene mutations, we’re not happy we have to recommend surgery so often to prevent cancer, but we know it works,” says Dr. Garber. “Now we have newly identified genes and significantly fewer people who’ve been tested for these genes. We haven’t had time yet to do the work that’s needed to tell them how much risk is associated with these mutations.”

However, Dr. Garber says we can expect progress much faster today than in previous years. “Many more women are being tested and agreeing to participate in research, and the technology networks for sharing information are much better.”

Who should consider this broader testing? It’s advisable for women who have had an ovarian or breast cancer diagnosis at any age, and for certain women who have had a cancer diagnosis before age 50, history. It’s also recommended for regardless of their family women who have a family history of cancer that is not explained by other genetic testing. Genetic counselors can provide more personalized guidance.

“The goal of cancer genetics is twofold: to help cancer patients who already have cancer, and to prevent cancer in their relatives,” Dr. Garber points out. “I’m confident these new technologies will ultimately enhance our ability to do both.”

Courtesy of Dana-Farber Cancer Institute

Turning Point

 

 

 

 

 

 

 

 

This entry was posted in BRCA 1 or BRCA2 genetic mutation, Breast Cancer, Breast Cancer Genetics, breast cancer research, cancer research, Dana-Farber, oncologist and tagged , , , , , , , , , .